PARADIGM-HF
PARADIGM-HF is the largest study to date in heart failure patients. 1
Summary:
The PARADIGM-HF study on systolic heart failure with 8,399 patients in NYHA class II-IV. 2,3...
- Twitter Linkedin Facebook Pinterest Google plus
PIONEER-HF
The recently presented PIONEER-HF studies the efficacy and safety of initiating ENTRESTO compared to enalapril prior to discharge after hospitalization for an acute decompensated heart failure episode. 1 The results of PIONEER-HF...
Twitter Linkedin Facebook Pinterest Google plusEfficacy - Entresto
ENTRESTO ® achieved superior outcomes vs Enalapril in the largest trial ever conducted in HFTwitter Linkedin Facebook Pinterest Google plusAsthme et BPCO : différentes
Dosing
Quand parle-t-on de l’asthme contrôlé ?
Si la réponse à ces questions est “non”, les symptômes de l’asthme sont contrôlés
Si la réponse est “oui” pour 1 ou 2 questions, l’asthme n’est que partiellement contrôlé.
Si la réponse est “oui” pour 3 ou 4 questions, l’...
Twitter Linkedin Facebook Pinterest Google plusMechanism of Action
TPO is the main cytokine involved in regulation of megakaryopoiesis and platelet production, and is the endogenous ligand for the TPO-R.Twitter Linkedin Facebook Pinterest Google plusPatient Resources
Mechanism of Action - Entresto
Sacubitril/valsartan, a first-in-class ARNI, delivers simultaneous inhibition of neprilysin and blockade of the AT1 receptor. Sacubitril/valsartan is a sodium salt complex comprising sacubitril (AHU377), a prodrug, which is further metabolized to the...
Twitter Linkedin Facebook Pinterest Google plusCosentyx zelf-injectie gids
Download Dutch version .field-name-field-np4-expiry-date {display:none;}